Paul M. Garofolo
Directeur Général chez Locus Biosciences, Inc.
Profil
Paul M.
Garofolo is the Chairman & Chief Executive Officer of Locus Biosciences, Inc., a company he founded in 2015.
He previously held the position of Chief Information Officer at Bausch Health Americas, Inc. and served as the Executive Vice President-Global PDS Operations at Patheon, Inc. from 2012 to 2014.
Additionally, he was the Chief Technology Officer at The Broadlane Group, Inc. Mr. Garofolo obtained his undergraduate degree from the University of Arizona.
Postes actifs de Paul M. Garofolo
| Sociétés | Poste | Début |
|---|---|---|
Locus Biosciences, Inc.
 Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Directeur Général | 01/01/2015 |
Anciens postes connus de Paul M. Garofolo
| Sociétés | Poste | Fin |
|---|---|---|
| PATHEON, INC. | Directeur Technique/Scientifique/R&D | 21/09/2012 |
The Broadlane Group, Inc.
 The Broadlane Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Broadlane Group, Inc. provides business and logistics consulting services for the healthcare industry. It offers supply chain management, strategic sourcing of supplies, professional sourcing, clinical workforce optimization, clinical and lean process consulting, operations and capital equipment lifecycle management solution. The company was founded in 1999 and is headquartered in Dallas, TX. | Directeur Technique/Scientifique/R&D | - |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Directeur Technique/Scientifique/R&D | - |
Formation de Paul M. Garofolo
| University of Arizona | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
The Broadlane Group, Inc.
The Broadlane Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Broadlane Group, Inc. provides business and logistics consulting services for the healthcare industry. It offers supply chain management, strategic sourcing of supplies, professional sourcing, clinical workforce optimization, clinical and lean process consulting, operations and capital equipment lifecycle management solution. The company was founded in 1999 and is headquartered in Dallas, TX. | Commercial Services |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Technology Services |
